Mannkind (MNKD) Cash from Investing Activities (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.41% |
| Dec 31, 2025 | -1,065.15% |
| Sep 30, 2025 | -500.54% |
| Jun 30, 2025 | 4.93% |
| Mar 31, 2025 | -87.64% |
| Dec 31, 2024 | 216.89% |
| Sep 30, 2024 | 25.23% |
| Jun 30, 2024 | -13.92% |
| Mar 31, 2024 | -513.51% |
| Dec 31, 2023 | 31.64% |
| Sep 30, 2023 | -415.20% |
| Jun 30, 2023 | -73.43% |
| Mar 31, 2023 | -8.11% |
| Dec 31, 2022 | -45.11% |
| Sep 30, 2022 | 1,252.52% |
| Jun 30, 2022 | 105.12% |
| Mar 31, 2022 | -214.06% |
| Dec 31, 2021 | -351.98% |
| Sep 30, 2021 | 104.44% |
| Jun 30, 2021 | -258.18% |
| Mar 31, 2021 | -601.29% |
| Dec 31, 2020 | -111,900.00% |
| Sep 30, 2020 | 97.33% |
| Jun 30, 2020 | -100.76% |
| Mar 31, 2020 | 9,926.73% |
| Dec 31, 2019 | -105.37% |
| Sep 30, 2019 | 374.73% |
| Jun 30, 2019 | 94.53% |
| Mar 31, 2019 | -10,159.43% |
| Jun 30, 2017 | -99.86% |
| Mar 31, 2016 | -261.22% |
| Dec 31, 2015 | 72.96% |
| Sep 30, 2015 | 74.55% |
| Jun 30, 2015 | -7.88% |
| Mar 31, 2015 | 70.43% |
| Dec 31, 2014 | -6,449.77% |
| Sep 30, 2014 | 97.37% |
| Jun 30, 2014 | -486.09% |
| Mar 31, 2014 | 77.15% |
| Dec 31, 2013 | -2,580.87% |
| Sep 30, 2013 | -74.24% |
| Jun 30, 2013 | 90.95% |
| Mar 31, 2013 | -2,291.80% |
| Dec 31, 2012 | 50.81% |
| Sep 30, 2012 | -47.62% |
| Jun 30, 2012 | 71.13% |
| Mar 31, 2012 | -132.80% |
| Dec 31, 2011 | 78.96% |
| Sep 30, 2011 | 85.34% |
| Jun 30, 2011 | -320.87% |
| Mar 31, 2011 | 122.62% |
| Dec 31, 2010 | -1,923.15% |